Global Medical Device Company Expands Deployment of BIO-key Biometric Authentication to Streamline Employee Training
August 31 2020 - 8:01AM
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider
of identity and access management (IAM) solutions powered by
biometrics, today announced that its long-time customer, global
medical device manufacturer ICU Medical, Inc., has expanded its use
of BIO-key biometric authentication to its new staff training
program, streamlining check-in and automating FDA compliance
recordkeeping.
ICU Medical has been successfully using BIO-key
biometric authentication solutions since 2005, initially to
streamline and automate an FDA-regulated Quality Control (QC)
signoff process within Oracle ERP during product manufacturing.
This lean-process innovation shaved significant time off the
production of their infusion products while ensuring in real-time
that the signing QC staff member was properly authorized and
trained to perform the specific QC process, compliant with Code of
Federal Regulations (CFR) 21 part 11.
As ICU Medical has grown over the past 15 years,
BIO-key biometric authentication has enabled the company to
seamlessly add users and worldwide locations without having to buy,
issue, or track any physical tokens for each staff member. The
integration of BIO-key has greatly simplified ICU Medical’s
onboarding and offboarding process.
Recently, ICU Medical wanted to add a secure,
user-friendly method to authenticate access to iLearning, a staff
training platform from Seertech that incorporates content,
accounting, and reporting functions. They leveraged the existing
successful BIO-key authentication platform for a larger group of
users and are seeing the benefits in terms of faster training
sign-ins, simplified accounting, and a better user experience.
“We are thrilled to see ICU Medical finding new
ways to streamline operations using their investment in BIO-key’s
one-touch, strong authentication,” stated Jim Sullivan, BIO-key SVP
of Strategy and Chief Legal Officer. “By adding BIO-key efficiency
to their digital learning initiatives, the company simplified the
process of maintaining its training requirements, while providing
its employees with the tools to make their jobs easier.”
About BIO-key International,
Inc.
(www.bio-key.com)BIO-key
is revolutionizing authentication with biometric solutions that
enable convenient and secure access to devices, information,
applications, and high-value transactions. BIO-key’s software and
hardware finger scanning solutions offer secure, user-friendly, and
attractively priced alternatives to passwords, PINs, tokens, and
security cards, enabling enterprises and consumers to secure their
networks and devices as well as their information in the cloud.
BIO-key Safe Harbor
StatementAll statements contained in this press release
other than statements of historical facts are “forward-looking
statements” as defined in the Private Securities Litigation Reform
Act of 1995 (the “Act”). The words “estimate,” “project,”
“intends,” “expects,” “anticipates,” “believes” and similar
expressions are intended to identify forward-looking statements.
Such forward-looking statements are made based on management’s
beliefs, as well as assumptions made by, and information currently
available to, management pursuant to the “safe-harbor” provisions
of the Act. These statements are not guarantees of future
performance or events and are subject to risks and uncertainties
that may cause actual results to differ materially from those
included within or implied by such forward-looking statements.
These risks and uncertainties include, without limitation, our
history of losses and limited revenue; our ability to raise
additional capital; our ability to protect our intellectual
property; changes in business conditions; changes in our sales
strategy and product development plans; changes in the marketplace;
continued services of our executive management team; security
breaches; competition in the biometric technology industry; market
acceptance of biometric products generally and our products under
development; our ability to execute and deliver on contracts in
Africa; our ability to expand into Asia, Africa and other foreign
markets; the duration and severity of the current coronavirus
COVID-19 pandemic and its effect on our business operations, sales
cycles, personnel, and the geographic markets in which we
operate; delays in the development of products and statements
of assumption underlying any of the foregoing as well as other
factors set forth under the caption see “Risk Factors” in our
Annual Report on Form 10-K for the year ended December 31, 2019 and
other filings with the Securities and Exchange Commission. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date made. Except as
required by law, the company undertakes no obligation to disclose
any revision to these forward-looking statements whether as a
result of new information, future events, or otherwise.
Additionally, there may be other factors of which the company is
not currently aware that may affect matters discussed in
forward-looking statements and may also cause actual results to
differ materially from those discussed. In particular, the
consequences of the coronavirus outbreak to economic conditions and
the industry in general and the financial position and operating
results of our company in particular have been material, are
changing rapidly, and cannot be predicted.
Facebook – Corporate: |
BIO-key
International |
Twitter – Corporate: |
@BIOkeyIntl |
Twitter – Investors: |
@BIO_keyIR |
StockTwits: |
BIO_keyIR |
Investor & Media
ContactsWilliam Jones, David CollinsCatalyst
IR212-924-9800bkyi@catalyst-ir.com
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Apr 2023 to Apr 2024